Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMEA completes the review of recombinant factor VIII products and inhibitor development 31 Ιούλιος 2007News Schering-Plough Europe withdraws its marketing authorisation applicationfor Garenoxacin mesylate 26 Ιούλιος 2007Press release Further questions and answers on the follow-up to the Viracept recall 26 Ιούλιος 2007News European Risk Management Strategy: Achievements to date 26 Ιούλιος 2007Press release Bausch & Lomb Ireland withdraws its marketing authorisation application for Retisert 23 Ιούλιος 2007Press release European Medicines Agency recommends withdrawal of medicinal products containing veralipride 23 Ιούλιος 2007Press releaseHumanMedicines Ark Therapeutics withdraws its marketing authorisation application for Cerepro 20 Ιούλιος 2007Press release Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 July 2007 19 Ιούλιος 2007Press releaseHuman European Medicines Agency holds Focus Group meeting on fibrosarcoma occurring at sites of injection of veterinary medicines in cats 19 Ιούλιος 2007Press releaseVeterinaryMedicines European Medicines Agency recommends authorisation of first generic medicine for human use 19 Ιούλιος 2007Press releaseGeneric and hybrid medicinesMedicines 1 … 321 322 323 324 325 Page 325 of 384 326 327 328 329 … 384
EMEA completes the review of recombinant factor VIII products and inhibitor development 31 Ιούλιος 2007News
Schering-Plough Europe withdraws its marketing authorisation applicationfor Garenoxacin mesylate 26 Ιούλιος 2007Press release
Bausch & Lomb Ireland withdraws its marketing authorisation application for Retisert 23 Ιούλιος 2007Press release
European Medicines Agency recommends withdrawal of medicinal products containing veralipride 23 Ιούλιος 2007Press releaseHumanMedicines
Ark Therapeutics withdraws its marketing authorisation application for Cerepro 20 Ιούλιος 2007Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 July 2007 19 Ιούλιος 2007Press releaseHuman
European Medicines Agency holds Focus Group meeting on fibrosarcoma occurring at sites of injection of veterinary medicines in cats 19 Ιούλιος 2007Press releaseVeterinaryMedicines
European Medicines Agency recommends authorisation of first generic medicine for human use 19 Ιούλιος 2007Press releaseGeneric and hybrid medicinesMedicines